Tolremo Therapeutics raises CHF4.7M from BioMed and Altos Ventures
20 June 2020
20 June 2020
Total investments received (USD): 39m
Round value (USD): 4.9m
Round investors:
BioMedPartners
Altos Ventures
Company: Tolremo Therapeutics
Related deals
MaxWell Biosystems secures CHF 4 million in a Series A round with Sensirion Holding AG
Investments
16 December 2020
Scailyte to raise pre-series A financing round with CHF 3.7 million led by Swisscom Ventures, joined by 4FO ventures, Hemex and investiere.
Investments
12 August 2020
MyoSwiss raised CHF 2.2 million and added T-Robotics as new investor in the company.
Investments
24 July 2020
Artiria Medical completed a CHF 3 million funding round led by 4FO Venture Partners.
Investments
15 July 2020
Positrigo raises CHF 3.9M from 4FO Ventures, Great Filter Ventures, Zurich Cantonal Bank, and ETH Zurich Foundation.
Investments
10 July 2020
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom